STTK: Shattuck Therapeutics O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati
Shattuck Labs, Inc. (STTK) o'zining tadqiqot barqarorligini ta'minlash uchun diversifikatsiyalashgan ishlab chiqarish bazalaridan foydalangan holda, o'simtalarni davolash ishlanmalari orqali daromad keltiradi. GURU.Markets kunlik grafigidagi PEG koeffitsiyenti trayektoriyasi biznes potentsialining bozor tomonidan baholanishini aks ettiradi, bunda 0.00 joriy ko'rsatkichni shakllantiradi. Shu bilan birga, Shattuck Labs, Inc. (STTK) innovatsion immunoterapiya dori vositalarini yaratishda klinik sinovlar etikasi va bioshafqatlik standartlariga qat'iy rioya qiladi.
Shattuck Labs, Inc. (STTK) kompaniyasi koʻrsatkichlari kesimi va tahlili
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- kompaniyaning balans qiymati tafsilotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning kapitalga nisbati Shattuck Labs, Inc.|STTK - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi shattucklabs.com|STTK - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar Shattuck Therapeutics|STTK - Kompaniyaning uzoq muddatli qarzi|Qisqa muddatli qarz hajmi Shattuck Labs|Oraliq qoplash koeffitsiyenti shattucklabs.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
STTK - Sof foyda|Prognoz qilingan kelajakdagi foyda Shattuck Labs, Inc.|STTK - Narx-foyda koeffitsiyenti|Kapitalizatsiyaning kelajakdagi foydaga nisbati shattucklabs.com|STTK - Narx-foyda va o‘sish multiplikatori|Korxona qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati koeffitsiyenti Shattuck Therapeutics|STTK - Eskirish chegirilmasdan oldingi operatsion foyda|Bir aksiya uchun sof foyda (EPS TTM) Shattuck Labs|STTK - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi 12 oy davomida bir aksiya uchun sof foydaning yillik o'sishi shattucklabs.com|STTK - Joriy yilda bir aksiya uchun foyda o'sishi|Keyingi yil uchun foyda o'sishi prognozi Shattuck Labs, Inc.
Kompaniyaning umumiy tahlili:STTK - Shattuck Labs Inc
PEG koeffitsiyenti foydalanilgan bozor qiymatini ularning o'sish sur'atiga nisbatda bog'laydi va qiymat birdan past bo'lganda qadrsiz baholangan aktivlarni aniqlaydi. Hozirgi o'rtacha peg_co darajasi 0.00 ni tashkil etadi, bu esa kengayish sur'atlariga nisbatan kapitalizatsiya potentsialini baholash imkonini beradi. Shattuck Labs, Inc. (STTK) uchun ushbu muvozanat juda muhimdir, chunki bispesifik proteinlarning kengayishi qat'iy xavfsizlik protokollari bilan cheklangan. Ushbu ko'rsatkich fundamental xavfsizlik zaxirasini klinik sinovlar xatarlaridan ajratishga yordam beradi. Past qiymat strategik hamkorlarning qo'llab-quvvatlashi sharoitida investitsiya jozibadorligini tasdiqlaydi.
Shattuck Labs, Inc. raqobatchilari
ARGX (argenx N.V.) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori BNTX (BioNTech Group)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Abivax (ABVX)|ADMA - Narxning foydaga va o‘sish sur’atiga nisbati|protagonist-inc.com (PTGX) - Narx-foyda va o‘sish multiplikatori|Immunovant (IMVT) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori Kiniksa Pharmaceuticals, Ltd.|Narx-foyda va o‘sish multiplikatori GRFS|PEG multiplikatori Adaptive Biotechnologies Inc.|Narxning foydaga va o‘sish sur’atiga nisbati Celldex Therapeutics (CLDX)|auriniapharma.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori BCRX (BioCryst Pharmaceuticals)|Vera Therapeutics Inc (VERA) - O‘sish sur’atiga tuzatilgan narx-foyda|DNTH - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Pharvaris Pharma PHVS|ABCL: PEG multiplikatori|tourmalinebio.com - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PGEN (Precigen) - PEG multiplikatori|PEG multiplikatori Pharming Group NV|Narx-foyda va o‘sish multiplikatori NKTR (Nektar)|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati UPB|Zenas Biopharma Inc - Narx-foyda va o‘sish multiplikatori|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati IMNM (immunome.com)|GOSS: Narx-foyda va o‘sish multiplikatori|KALV - PEG multiplikatori|SEPN: PEG multiplikatori|Narx-foyda va o‘sish multiplikatori Pieris Corp|Narxning foydaga va o‘sish sur’atiga nisbati Savara Inc.|PEG multiplikatori rigel.com|Narx-foyda va o‘sish multiplikatori ANAB (AnaptysBio)|ATXS (Astria Therapeutics Inc) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati enGene Bio ENGN|rapt.com - Narxning foydaga va o‘sish sur’atiga nisbati|Aerovate - PEG multiplikatori|ACRS - PEG multiplikatori|KYTX: PEG multiplikatori|TLSA (Tiziana Life Sciences Ltd.) - Narxning foydaga va o‘sish sur’atiga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Cabaletta Bio, Inc|Ventyx Biosciences, Inc (VTYX) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narx-foyda va o‘sish multiplikatori THTX (Theratechnologies Inc.)|AVTX (avalotx.com) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori ELDN (Eledon Pharmaceuticals, Inc.)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Agenus, Inc. (AGEN)|CLYM - Narxning foydaga va o‘sish sur’atiga nisbati|ZURA (zurabio.com) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|ATYR: PEG multiplikatori|Narx-foyda va o‘sish multiplikatori Adagene Inc.|Narx-foyda va o‘sish multiplikatori IMA|Equillium Bio (EQ) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Connect Biopharma (CNTB)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati immunic-therapeutics.com|Atara Bio - Narx-foyda va o‘sish multiplikatori|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati IFRX (InflaRx NV)|XFOR: Narx-foyda va o‘sish multiplikatori|Adicet Bio - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|celularity.com (CELU) - Narxning foydaga va o‘sish sur’atiga nisbati|INmune Bio Corporation (INMB) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati Barinthus Biotherapeutics|kezarlifesciences.com - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|PEG multiplikatori SABS|AKTX (Akari Therapeutics PLC) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori ENLV (Enlivex Therapeutics Ltd.)|PEG multiplikatori Q32 Bio Inc QTTB|GOVX - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti EDSA (edesabiotech.com)|iBio (IBIO) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori Carisma Therapeutics Inc.|XTLB (XTL Biopharmaceuticals, Ltd.) - PEG multiplikatori|PEG multiplikatori Bolt Bio|Narx-foyda va o‘sish multiplikatori HCWB (HCW Biologics Inc.)|APVO (aptevotherapeutics.com) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori AIM (AIM ImmunoTech)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Aditxt Inc. (ADTX)|GRI - Narxning foydaga va o‘sish sur’atiga nisbati|XORTX Corp (XRTX) - Narx-foyda va o‘sish multiplikatori|Vyome Holdings Inc (HIND) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori revbiosciences.com|Narx-foyda va o‘sish multiplikatori INDP|PEG multiplikatori Scinai Immunotherapeutics Ltd|Narxning foydaga va o‘sish sur’atiga nisbati CalciMedica, Inc. (CALI)|affimed.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori ALLK (Allakos)|HOOKIPA Pharma, Inc. (HOOK) - O‘sish sur’atiga tuzatilgan narx-foyda|IGMS - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati iTeos Therapeutics Inc ITOS|OCEA: PEG multiplikatori|TC BioPharm Ltd - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|THRD (Third Harmonic Bio) - PEG multiplikatori
